AliveCor’s FDA-cleared 6-lead ECG aims to detect more than the Apple Watch
The KardiaMobile 6L should better detect cardiovascular diseases, is available in June.
Scott SteinEditor at Large
I started with CNET reviewing laptops in 2009. Now I explore wearable tech, VR/AR, tablets, gaming and future/emerging trends in our changing world. Other obsessions include magic, immersive theater, puzzles, board games, cooking, improv and the New York Jets. My background includes an MFA in theater which I apply to thinking about immersive experiences of the future.
ExpertiseVR and AR, gaming, metaverse technologies, wearable tech, tabletsCredentials
Nearly 20 years writing about tech, and over a decade reviewing wearable tech, VR, and AR products and apps
and Android-compatible KardiaMobile 6L is the only consumer-sold six-lead ECG (other portable devices, like AliveCor's nearly identical-looking but cheaper KardiaMobile, can only record one lead). It can record heart activity on six different leads at once (I, II, II, aVL, aVR and aVF). It can detect atrial fibrillation (AFib), bradycardia (abnormally low heart rate) and tachycardia (abnormally high heart rate), but promises to also detect other arrhythmias that could indicate heart disease.
Watch this: Withings adds ECG to its newest watches and blood pressure cuffs at CES 2019
AliveCor CEO Ira Bahr said in a statement in AliveCor's press release, "KardiaMobile 6L is the most clinically valuable personal ECG ever created, and another significant step in AliveCor's march to making heart care more convenient, more accessible, and less expensive than ever before."
The little device has three electrodes, and requires thumbs from each hand to make contact, as well as an ankle or knee on the bottom. The completion of all of those contact points allows a 30-second timed reading that can be shared with a doctor afterward.
A six-lead ECG should offer a considerable step up in awareness of potential cardiovascular conditions, although it's still not the same as a 12-lead ECG like you'd get from a cardiologist. It'll be available in June, with preorders available now in the US.